JP2023544614A5 - - Google Patents

Info

Publication number
JP2023544614A5
JP2023544614A5 JP2023521190A JP2023521190A JP2023544614A5 JP 2023544614 A5 JP2023544614 A5 JP 2023544614A5 JP 2023521190 A JP2023521190 A JP 2023521190A JP 2023521190 A JP2023521190 A JP 2023521190A JP 2023544614 A5 JP2023544614 A5 JP 2023544614A5
Authority
JP
Japan
Application number
JP2023521190A
Other languages
Japanese (ja)
Other versions
JP2023544614A (ja
JPWO2022073062A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2021/051160 external-priority patent/WO2022073062A1/en
Publication of JP2023544614A publication Critical patent/JP2023544614A/ja
Publication of JP2023544614A5 publication Critical patent/JP2023544614A5/ja
Publication of JPWO2022073062A5 publication Critical patent/JPWO2022073062A5/ja
Pending legal-status Critical Current

Links

JP2023521190A 2020-10-05 2021-10-05 Clec9a抗体 Pending JP2023544614A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2020903586 2020-10-05
AU2020903586A AU2020903586A0 (en) 2020-10-05 Clec9A antibodies
PCT/AU2021/051160 WO2022073062A1 (en) 2020-10-05 2021-10-05 Clec9a antibodies

Publications (3)

Publication Number Publication Date
JP2023544614A JP2023544614A (ja) 2023-10-24
JP2023544614A5 true JP2023544614A5 (https=) 2024-10-18
JPWO2022073062A5 JPWO2022073062A5 (https=) 2024-10-18

Family

ID=81127084

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023521190A Pending JP2023544614A (ja) 2020-10-05 2021-10-05 Clec9a抗体

Country Status (6)

Country Link
US (1) US20230374142A1 (https=)
EP (1) EP4225795A4 (https=)
JP (1) JP2023544614A (https=)
CN (1) CN116547003A (https=)
AU (1) AU2021356294A1 (https=)
WO (1) WO2022073062A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009026660A1 (en) * 2007-08-30 2009-03-05 Walter And Eliza Hall Institute Of Medical Research Dendritic cell marker and uses thereof
US20110110861A1 (en) * 2008-05-13 2011-05-12 Mireille Hanna Lahoud Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells
CA3049842A1 (en) * 2017-02-02 2018-08-09 Silverback Therapeutics, Inc. Construct-peptide compositions and methods of use thereof
KR20220007584A (ko) * 2019-02-11 2022-01-18 주무토르 바이오로직스 인코포레이티드 항-clec2d 항체 및 이의 사용 방법
CN120590542A (zh) * 2019-03-28 2025-09-05 奥里尼斯生物科学股份有限公司 基于clec9a的嵌合蛋白复合物

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
JP2022521705A5 (https=)
BR112023009656A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
JP2023544614A5 (https=)
BR102021016837A2 (https=)
BR102021016375A2 (https=)
BR102021015566A2 (https=)
BR102021015450A8 (https=)
BR102021015247A2 (https=)
BR102021015220A2 (https=)
BR102021014056A2 (https=)
BR102021014044A2 (https=)
BR102021013929A2 (https=)
BR102021012571A2 (https=)